Skip to content

Reducing Opioid Use for Chronic Pain Patients Following Surgery

Postoperative Pain | Opioid Use | Chronic Pain | Opioid Dependence

Patients with chronic pain are often prescribed long-term opioid therapy, despite the serious risks and growing concerns related to opioid use. The Toronto General Hospital has created the world's first multidisciplinary perioperative Transitional Pain Service Program (TPSP) aimed at reducing the incidence and severity of chronic post-surgical pain. The TPSP incorporates a variety of mechanisms and interventions to help patients manage pain and to wean off opioids. The approach consists of: pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile self- management tool to help patients manage chronic pain more effectively. With the TPSP team, the investigators hope to continually assist patients to achieve a balance between the benefits and potential harms of opioid use to promote long-term health and well-being.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* ≥ 18 years of age
* Taking 20 -- 200 mg of preoperative oral morphine equivalents daily
* Any type of surgical procedure, with the exception of those with palliative intent or organ transplantation
* Able to read and understand English as posed on the questionnaire surveys prior to informed consent
* Must be taking opioids for at least one month prior to their operation
* Must have a personal email address for the set-up of the Manage My Pain (MMP) App or online multimedia tool

Exclusion Criteria:

• Subjects who are undergoing palliative care or procedures, organ transplantation, or prescribed with Methadone/Buprenorphine will be excluded from the trial

Study Location

Toronto General Hospital- University Health Network
Toronto General Hospital- University Health Network
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Karim Ladha, MD

[email protected]
(416) 719-0030
Backup Contact

Hance Clarke, MD, PhD

[email protected]
(416) 340-4800
Study Sponsored By
University Health Network, Toronto
Participants Required
More Information
Study ID: NCT03675386